Back

W. (Rik) Nooijer MSc

W. (Rik) Nooijer MSc

PHD Candidate - OIO
W. (Rik) Nooijer MSc
  • Department of Medical Oncology

Research Programs

Strategic Program Cancer

Research Output (6)

TNF inhibition for immune checkpoint inhibitor-induced irAEs:the jury is still out

Suijkerbuijk Karijn P M, Verheijden Rik J 8 Jun 2021, In: Nature Reviews. Rheumatology. 17 , p. 505 1 p.

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events-A Comprehensive Review

Hommes Josefien W, Verheijden Rik J, Suijkerbuijk Karijn P M, Hamann Dörte 11 Feb 2021, In: Frontiers in oncology. 10

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease

Verheijden Rik J, May Anne M, Blank Christian U, van der Veldt Astrid A M, Boers-Sonderen Marye J, Aarts Maureen J B, van den Berkmortel Franchette W P J, van den Eertwegh Alfonsus J M, de Groot Jan Willem B, van der Hoeven Jacobus J M, Hospers Geke A P, Piersma Djura, van Rijn Rozemarijn S, Ten Tije Albert J, Vreugdenhil Gerard, van Zeijl Michiel C T, Wouters Michel W J M, Haanen John B A G, Kapiteijn Ellen, Suijkerbuijk Karijn P M Nov 2020, In: ESMO open. 5 , p. e000945

Association of anti-TNF with decreased survival in steroid refractory ipilimumab and anti-PD1 treated patients in the Dutch Melanoma Treatment Registry

Verheijden Rik J, May Anne M, Blank Christian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, van den Eertwegh Alfonsus J M, de Groot Jan Willem B, Boers-Sonderen Marye J, van der Hoeven Jacobus J M, Hospers Geke A, Piersma Djura, van Rijn Rozemarijn S, Ten Tije Albert, van der Veldt Astrid Am, Vreugdenhil Gerard, van Zeijl Michiel C T, Wouters Michel W J M, Haanen John B A G, Kapiteijn Ellen, Suijkerbuijk Karijn Pm 27 Jan 2020, In: Clinical Cancer Research. 26 , p. 2268-2274 7 p.

Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors

Suijkerbuijk Karijn P M, Kapiteijn Ellen, Verheijden Rik J 1 Jan 2020, In: JAMA Oncology. 6 , p. 1300-1301 2 p.

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

Schuiveling M, Tonk E H J, Verheijden R J, Suijkerbuijk K P M 2020, In: Cancer Immunology, Immunotherapy. 70 , p. 1491-1496 6 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not